February 2025 Price Concessions 3rd Update
Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (27/02/2025) announced the following list of price concessions for February 2025:
Please note: Following a mid-month price increase reported by pharmacy owners, Community Pharmacy England has secured an upward price adjustment for the product listed in the table below.
- Prucalopride 2mg tablets
This is not the final update for February. We are still working with the DHSC to agree concessionary prices for other drugs reported to be unavailable at the stated February 2025 Drug Tariff prices. Please note: We are unable to provide details of any generic products awaiting price concession approval from DHSC.
Drug | Pack size | Price concession |
Buprenorphine 8mg sublingual tablets sugar free | 7 | £4.98 |
Calcium and Ergocalciferol tablets | 28 | £6.82 |
Captopril 25mg tablets | 56 | £22.45 |
Clotrimazole 500mg pessary and Clotrimazole 2% cream | 1 | £6.30 |
Codeine 15mg/5ml linctus | 200 | £16.50 |
Diclofenac potassium 50mg tablets | 28 | £7.41 |
Lidocaine 2% cream | 30 | £3.81 |
Memantine 20mg tablets | 28 | £3.69 |
Mometasone 0.1% cream | 30 | £3.59 |
Oxybutynin 5mg tablets | 56 | £3.50 |
Propantheline bromide 15mg tablets | 112 | £103.33 |
Prucalopride 2mg tablets | 28 | £10.94 (previously £10.00) |
Riluzole 50mg tablets | 56 | £361.07 |
For the full list of price concessions granted for February 2025 so far please visit our price concession hub page here.
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) Please see our latest funding and reimbursement short videos for further information on the recent changes to the price concession process.